Goodwin advised Paindrainer AB on its commercial partnership agreement with Dr. Edward Rubin. Paindrainer AB announced a commercial partnership agreement with Dr. Edward Rubin, Past President of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised STALICLA SA on the deal. STALICLA SA announced its exclusive in-licensing agreement with Novartis to develop mavoglurant as a treatment for substance-use disorder, neurodevelopmental...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Envisagenics, Inc. on the deal. Envisagenics, Inc. announced a research collaboration agreement with Bristol Myers Squibb Company (NYSE: BMY). The multi-year collaboration will leverage...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised STALICLA on the deal. STALICLA announced its worldwide in-licensing of SFX-01, a patented composition of synthetic sulforaphane and alpha-cyclodextrin, from Evgen Pharma in neurodevelopmental...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Vinge advised Byggfakta Group on the deal, while White & Case advised the underwriters. Byggfakta Group HQ AB announced a Swedish public offering with...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised the underwriters on the deal, while Dechert advised Femasys. Chardan, a global investment bank, announced that it acted as lead left bookrunner in...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Cathay Health, Polaris Partners, and Newpath Partners on the deal. Cathay Health, Polaris Partners, and Newpath Partners lead the Kojin Therapeutics’ $60 Million Series...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Envisagenics on the deal. Envisagenics announced its collaboration with Biogen Inc. (Nasdaq: BIIB) to advance ribonucleic acid (RNA) splicing research within central nervous...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP and Advokatfirman Delphi advised Olink Holding AB on the deal, while Baker McKenzie legal advisor to minority selling shareholders. Sweden-based Olink Holding AB...
You must be a Standard 1 Year member to access this content.
